Patent application number | Description | Published |
20080242678 | Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin. | 10-02-2008 |
20090023712 | Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin - The invention relates to new pharmaceutical compositions for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment ADHD and methods for the preparation thereof. | 01-22-2009 |
20090137545 | Compounds - The present invention relates to compounds of general formula I | 05-28-2009 |
20090247546 | Treatment of Prevention of Valvular Heart Disease with Flibanserin - The invention relates to a method for the treatment or prevention of Valvular Heart Disease comprising the administration of a therapeutically effective amount of flibanserin. | 10-01-2009 |
20100022558 | TREATMENT OF INSOMNIA - The invention relates to the use of Flibanserin for the preparation of medicaments useful for the treatment of Insomnia. | 01-28-2010 |
20100197664 | NOVEL B1-ANTAGONISTS - Disclosed are compounds of the formula I | 08-05-2010 |
20100240669 | NEW COMPOUNDS - The present invention relates to the compounds of general formula I | 09-23-2010 |
20110021488 | New Compounds - The present invention relates to compounds of general formula I | 01-27-2011 |
20110046106 | ARYL SULFONAMIDES AS EFFECTIVE ANALGESICS - The present invention relates to compounds of general formula I | 02-24-2011 |
20110077231 | COMPOUNDS - Novel compounds, with the following being exemplary: | 03-31-2011 |
20110098282 | NEW COMPOUNDS - Novel compounds of which the following is exemplary: | 04-28-2011 |
20110263626 | NOVEL BRADYKININ B1-ANTAGONISTS - The present invention relates to compounds of general formula I | 10-27-2011 |
20110294775 | NOVEL COMPOUNDS - Novel compounds which are useful for treating acute pain, visceral pain, neuropathic pain, inflammatory/pain receptor-mediated pain, tumour pain and headache diseases. The following is exemplary: | 12-01-2011 |
20120142695 | COMPOUNDS AS BRADYKININ B1 ANTAGONISTS - Compounds of the formula I | 06-07-2012 |
20120208823 | New Compounds - Disubstituted tetrahydrofuranyl compounds of general formula I | 08-16-2012 |
20130079355 | Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin. | 03-28-2013 |
20130131075 | NEW COMPOUNDS - The present invention relates to the compounds of general formula I | 05-23-2013 |
20150072994 | Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin. | 03-12-2015 |